ClinicalTrials.gg
CompletedNCT02909985Updated Dec 13, 2024Results posted

Visual Activity Evoked by Infrared in Humans After Dark Adaptation

An interventional study of Tungsten halogen light with narrow bandpass filters in Age Related Macular Degeneration, Retinitis Pigmentosa and Congenital Stationary Night Blindness, sponsored by University of New Mexico. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-12-13.

Sponsored by University of New Mexico · Not applicable, Interventional, and Diagnostic

Phase
Not applicable
Study type
Interventional
Enrollment
21
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

This pilot study will evaluate the visual response to infrared (IR) in humans after dark adaptation. The investigators plan to determine which wavelength and intensity the human eye is most sensitive to in healthy and color-blind participants by using a broad spectrum light source and wavelength-specific IR bandpass filters.

The long-term goal of this research is to better understand the role that IR plays in visual function, and whether this can be manipulated to allow for vision in certain retinal pathologies that result from loss of photoreceptor cells. The investigators central objective is to test the electrophysiologic response to IR in the dark-adapted retinal and visual pathways. The investigator's central hypothesis is that IR evokes a visual response in humans after dark adaptation, and the characteristics of this response suggest transient receptor potential (TRP) channel involvement. The investigators rationale is that a better understanding of how IR impacts vision may allow for an alternative mechanism for vision in a number of diseases that cause blindness from the degradation or loss of function of photoreceptor cells. The investigators will test the investigator's hypothesis with the following Aims:

Aim 1:

Arm 1: To determine the optimal IR wavelength for visual perception in dark-adapted human participants. The investigators hypothesize that the healthy human eye will detect IR irradiation, with a maximum sensitivity at a specific wavelength. Using a broad-spectrum light source with wavelength-specific bandpass filters, the spectral range of visual perception to IR will be evaluated.

Arm 2: To determine the optimal IR wavelength for visual perception in dark-adapted human participants who are colorblind. The investigators hypothesize that the colorblind human eye will detect IR irradiation, with a maximum sensitivity at a specific wavelength. Using a broad-spectrum light source with wavelength-specific bandpass filters, the spectral range of visual perception to IR will be evaluated.

Read the detailed description

BACKGROUND: Visual impairment affects 285 million people worldwide. The prevalence of visual impairment in the US is expected to rise from 3.3 million in 2000 to 5.5 million in 2020. This will exacerbate the current economic burden of vision loss, which is already $38.2 billion per year in direct and indirect costs. The leading cause of blindness in high-income countries is due to age-related macular degeneration (AMD), a disease that leads to gradual loss of the photoreceptor cell layer. An estimated 1.75 million people have AMD in the US and another 7.3 million are at risk. Importantly, despite the loss of photoreceptor cells in AMD, the other cellular layers in the retina remain largely intact.

The retina lines the back of the eye and is composed of structural layers. The outer nuclear layer contains photoreceptors called rods and cones. The inner nuclear layer includes bipolar, horizontal, and amacrine cells. Most anteriorly, the ganglion cell layer has axons that exit the eye as the optic nerve. Visual image formation begins when a photon of light enters the eye, passes through all retinal layers, and is absorbed by the photoreceptor cells. These cells transduce the photon of light into an electrochemical signal, which is communicated to bipolar cells, followed by the ganglion cells. Here, an action potential is generated and propagated via the optic nerve to the area of the brain where vision perception occurs. When the eye is dark-adapted, the cells in this pathway are potentially more sensitive to other types of stimuli, such as IR. The investigators believe cation channels called TRP channels in ganglion cells are activated by IR in this dark-adapted state, creating the visual response to IR. Heat is a known activator of certain subtypes of these channels elsewhere in the body. TRP channels are also responsible for IR vision in pit vipers and vampire bats.

Palczewska et al. reported that visual perception to IR occurred through a process of direct two-photon isomerization of visual pigments. However, other evidence suggests IR perception can occur through single IR photon absorption. Studies that use IR to test the functionality of implanted visual prosthesis have noted a greater response to IR in the non-implanted eye when compared to the implanted eye on both VEP tests and ERG. On ERG, a specialized response specific to IR was found called the scotopic threshold response (STR). This response occurs under dark-adapted conditions and correlates with a response at the ganglion cell layer. Direct IR activation of TRP channels on ganglion cells could initiate a visual response. Based on these findings, the investigators hypothesize the human response to IR under dark adaptation occurs at the level of the ganglion cells through heat-activated TRP channels.

RESEARCH DESIGN AIM1: To determine the optimal IR wavelength for human visual perception while dark-adapted in the healthy human eye.

Introduction for Aim 1: The objective of this aim is to determine the optimal wavelength of IR to which the human eye is sensitive. To obtain this objective, the investigators will test the working hypothesis that the healthy human eye, and those with colorblindness, will detect a range of IR wavelengths, with a preference for a specific wavelength. The investigators will test the working hypothesis using a broad-spectrum light source with wavelength-specific bandpass filters in the IR range. The investigators' rationale for this aim is that understanding the optimal IR wavelength of the human eye will aid in future investigations when testing the visual response to IR using diagnostic equipment. This is important because it could impact the way other ophthalmologic modalities use IR to diagnose and treat visual pathologies.

Research Design for Aim 1: A total of healthy 21 participants (15 with normal vision and 6 with colorblindness) aged 18 and older will be recruited using the University of New Mexico (UNM) Clinical and Translational Science Center (CTSC) Clinical Research Volunteer Registry HRRC-06412. Informed consent, participant demographics, past medial and visual history, and a general eye exam will be obtained using the CTSC research coordinator. Each participant will be placed in a dark room for an hour to allow for optimal dark adaptation of the eye. The investigators will use a broad-spectrum light source with wavelength-specific bandpass filters of different IR wavelengths. A total of 12 filters will be used ranging from 850 nm to 1400nm. Intensity curves will be built for each wavelength, by slowly turning up the power until the participant indicates a visual response to the stimulus.

Data Analysis for Aim 1: Data will be analyzed by the investigators. Descriptive statistics will be used to evaluate demographics, general and visual health information, and reported optimal wavelengths. The investigators' analysis will compare differences among responses for each wavelength. To the investigators' knowledge, there have been no studies evaluating which IR wavelength is optimal for human visual perception, thus the investigators assume a low effect size of 10%, which would produce an 82% chance of at least two out of 30 healthy participants giving a preferred response to a specific wavelength. The investigators will describe the estimated effect sizes in response to the findings.

Expected Outcomes for Aim 1: The investigators expect the human eye to perceive a range of IR wavelengths, but have a specific wavelength optimal in terms of brightness.

Potential Problems \& Alternative Strategies for Aim 1: To prevent sampling bias, the investigators plan to obtain a representative sample from New Mexico; however, participants may be younger and more educated than the general population. The confounding bias of light pollution may occur, which would prevent dark adaptation and decrease the IR sensitivity. A photometer will assess the room for background photons.

02

Conditions studied

  • Age Related Macular Degeneration
  • Retinitis Pigmentosa
  • Congenital Stationary Night Blindness
  • Colorblindness

Keywords

  • Infrared
  • Dark Adaptation
  • Vision
  • Scotopic Threshold Response
  • Transient Receptor Potential (TRP) Channels
  • Human
03

In context

Macular Degeneration

1,459 studies on the registry are indexed under Macular Degeneration; 238 are open to participants now.

This study's enrollment of 21 is below the median of 56 across 985 interventional studies indexed under Macular Degeneration.

Browse Macular Degeneration studies →

Lead sponsor

University of New Mexico is the lead sponsor of 313 studies on the registry; 29 are open to participants now.

Of its 25 completed or terminated interventional studies of FDA-regulated products, 23 (92%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Normal Vision
  • Colorblindness
  • Age related macular degeneration
  • Congenital Stationary Night Blindness

Exclusion criteria

Exclusion Criteria:

  • Diabetes
  • Heart disease
  • History of eye injury
  • History of eye trauma
  • History of eye disease except for those specified in the inclusion criteria
  • Pregnant women will also be excluded from Aim 2 and 3
  • Persons with allergies to adhesives will be excluded from Aim 2 and 3
  • Contact dermatitis
  • Documented adverse reaction to dilating drops
  • Documented adverse reaction to topical anesthetics
  • Vulnerable populations
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
21 participants (actual)

Study arms

  • Experimental
    Visual response to IR in healthy eyes

    15 healthy participants will describe IR light passing through narrow bandpass filters over a broad-spectrum light source. As intensity increases from 0 to 12 V, participants will say if/when they see a visual response to infrared light from a broadband Tungsten halogen light with narrow bandpass filters ranging from 850 nm to 1400 nm. At the end of three trials per filter, the intensity will be turned up to 12 V, and participants will describe the color they see.

    Other: Tungsten halogen light with narrow bandpass filters

  • Experimental
    Visual response to IR in colorblind eyes

    6 colorblind participants will describe IR light passing through narrow bandpass filters over a broad-spectrum light source. As intensity increases from 0 to 12 V, participants will say if/when they see a visual response to infrared light from a broadband Tungsten halogen light with narrow bandpass filters ranging from 850 nm to 1400 nm. At the end of three trials per filter, the intensity will be turned up to 12 V, and participants will describe the color they see.

    Other: Tungsten halogen light with narrow bandpass filters

Interventions

  • OtherTungsten halogen light with narrow bandpass filters

    As intensity in increased from 0 to 12 V, participants will say if/when they see a visual response to infrared light from a broad band tungsten halogen light source that passes through narrow bandpass filters ranging from 850 nm to 1400 nm. At the end of three trials per filter, the intensity will be turned up to 12 V, and participants will describe the color they see.

06

What researchers measure

Primary outcomes

  1. Visual Perception to Infrared: Mean Minimal Intensity (uW) at Which Participants Could See IR Between 900 - 1400 nm.

    We measured the minimum threshold intensities (uW) via subjective perception of near IR light (900 - 1400 nm) in 50 nm intervals. After 30 minutes of dark adaptation and over three trials, participants verbalized by saying 'yes' to the minimal intensity they could see the IR stimulus as the power source for the light was slowly increased from 0V to 12 V. The voltage was averaged for the three trials at each wavelength. Analysis of variance was used to evaluate the effect of the wavelength on the threshold intensity. This was done for two groups/arms, one with normal color vision and one with colorblind vision.

    Time frame: after 30 minutes of dark adaptation, up to 2 hours

Secondary outcomes

  1. Description of Color

    A subjective description of color was given by each participant for each wavelength between 850 - 1400nm while at 12V.

    Time frame: after 30 minutes of dark adaptation, up to 2 hours

07

Results

Posted Dec 13, 2024
Limitations and caveats
Color descriptions vary among individuals. Our sample size was too small to permit any assessment of gender bias. We were unable to standardize color descriptions with a reference color chart, as it was important to maintain dark adaptation in our participants. A color chart likely would have made this data more meaningful in understanding the colors reported and perceived by these participants.

Participant flow

Healthy adult participants with normal vision or who are colorblind were recruited using the University of New Mexico CTSC Clinical Research Volunteer Registry (HRRC 06-412), a Craigslist advertisement, and word of mouth.

Participant flow — Overall Study
MilestoneVisual Response to IR
Started21
Completed21
Not completed0

Outcome measures

PrimaryVisual Perception to Infrared: Mean Minimal Intensity (uW) at Which Participants Could See IR Between 900 - 1400 nm.

We measured the minimum threshold intensities (uW) via subjective perception of near IR light (900 - 1400 nm) in 50 nm intervals. After 30 minutes of dark adaptation and over three trials, participants verbalized by saying 'yes' to the minimal intensity they could see the IR stimulus as the power source for the light was slowly increased from 0V to 12 V. The voltage was averaged for the three trials at each wavelength. Analysis of variance was used to evaluate the effect of the wavelength on the threshold intensity. This was done for two groups/arms, one with normal color vision and one with colorblind vision.

Time frame:
after 30 minutes of dark adaptation, up to 2 hours
Reported as:
Mean · uW
Visual Perception to Infrared: Mean Minimal Intensity (uW) at Which Participants Could See IR Between 900 - 1400 nm.
uWNormal Color VisionColorblind Vision
850 nm0.671770454 ± 0.0990313060.809204 ± 0.141801
900 nm0.205456012 ± 0.0374810070.222247 ± 0.042895
950 nm0.281608408 ± 0.0707296460.545299 ± 0.571049
1000 nm1.144748348 ± 0.6079655041.056031 ± 0.792399
1050 nm1.272084129 ± 0.6725949051.397371 ± 0.90500
1100 nm0.258018884 ± 0.0892760040.367814 ± 0.205764
1150 nm1.353030502 ± 0.9115314872.144498 ± 1.049761
1200 nm0.345439815 ± 0.1439855580.422416 ± 0.119660
1250 nm0.341422349 ± 0.1943583830.505195 ± 0.229724
1300 nm0.153133406 ± 0.0974933190.198776 ± 0.095276
1350 nm0.119277641 ± 0.08813920.182666 ± 0.067348
1400 nm0.419039248 ± 0.1589781020.601534 ± 0.184694
Statistical analysis
  • Normal Color Vision · ANOVA · p = <0.0001 · F: 23.68(9, 129)
  • Colorblind Vision · ANOVA · p = <0.0001 · F: 9.4394(11, 52)
SecondaryDescription of Color

A subjective description of color was given by each participant for each wavelength between 850 - 1400nm while at 12V.

Time frame:
after 30 minutes of dark adaptation, up to 2 hours
Reported as:
Count of participants · Participants
Description of Color
ParticipantsVisual Response to IR in Colorvision EyesVisual Response to IR in Colorblind Eyes
Color perception at 850 λ — Red124
Color perception at 850 λ — Dark Red30
Color perception at 850 λ — Orange01
Color perception at 850 λ — Yellow00
Color perception at 850 λ — Light brown00
Color perception at 850 λ — Light blue00
Color perception at 850 λ — Blue00
Color perception at 850 λ — Light Purple00
Color perception at 850 λ — White00
Color perception at 850 λ — Grey00
Color perception at 850 λ — Teal Green00
Color perception at 850 λ — Green01
Color perception at 850 λ — Light Green00
Color perception at 850 λ — Black (no color)00
Color perception at 850 λ — Pink00
Color perception at 900 λ — Red41
Color perception at 900 λ — Dark Red10
Color perception at 900 λ — Orange72
Color perception at 900 λ — Yellow00
Color perception at 900 λ — Light brown00
Color perception at 900 λ — Light blue00
Color perception at 900 λ — Blue00
Color perception at 900 λ — Light Purple00
Color perception at 900 λ — White00
Color perception at 900 λ — Grey00
Color perception at 900 λ — Teal Green01
Color perception at 900 λ — Green01
Color perception at 900 λ — Light Green01
Color perception at 900 λ — Black (no color)10
Color perception at 900 λ — Pink20
Color perception at 950 λ — Red01
Color perception at 950 λ — Dark Red10
Color perception at 950 λ — Orange40
Color perception at 950 λ — Yellow22
Color perception at 950 λ — Light brown50
Color perception at 950 λ — Light blue00
Color perception at 950 λ — Blue00
Color perception at 950 λ — Light Purple10
Color perception at 950 λ — White10
Color perception at 950 λ — Grey01
Color perception at 950 λ — Teal Green00
Color perception at 950 λ — Green00
Color perception at 950 λ — Light Green01
Color perception at 950 λ — Black (no color)00
Color perception at 950 λ — Pink11
Color perception at 1000 λ — Red10
Color perception at 1000 λ — Dark Red00
Color perception at 1000 λ — Orange10
Color perception at 1000 λ — Yellow00
Color perception at 1000 λ — Light brown00
Color perception at 1000 λ — Light blue10
Color perception at 1000 λ — Blue00
Color perception at 1000 λ — Light Purple00
Color perception at 1000 λ — White11
Color perception at 1000 λ — Grey00
Color perception at 1000 λ — Teal Green10
Color perception at 1000 λ — Green00
Color perception at 1000 λ — Light Green00
Color perception at 1000 λ — Black (no color)105
Color perception at 1000 λ — Pink00
Color perception at 1050 λ — Red00
Color perception at 1050 λ — Dark Red00
Color perception at 1050 λ — Orange00
Color perception at 1050 λ — Yellow00
Color perception at 1050 λ — Light brown00
Color perception at 1050 λ — Light blue20
Color perception at 1050 λ — Blue00
Color perception at 1050 λ — Light Purple00
Color perception at 1050 λ — White30
Color perception at 1050 λ — Grey01
Color perception at 1050 λ — Teal Green20
Color perception at 1050 λ — Green00
Color perception at 1050 λ — Light Green00
Color perception at 1050 λ — Black (no color)85
Color perception at 1050 λ — Pink00
Color perception at 1100 λ — Red00
Color perception at 1100 λ — Dark Red00
Color perception at 1100 λ — Orange21
Color perception at 1100 λ — Yellow51
Color perception at 1100 λ — Light brown00
Color perception at 1100 λ — Light blue00
Color perception at 1100 λ — Blue00
Color perception at 1100 λ — Light Purple10
Color perception at 1100 λ — White30
Color perception at 1100 λ — Grey21
Color perception at 1100 λ — Teal Green00
Color perception at 1100 λ — Green01
Color perception at 1100 λ — Light Green01
Color perception at 1100 λ — Black (no color)10
Color perception at 1100 λ — Pink11
Color perception at 1150 λ — Red10
Color perception at 1150 λ — Dark Red00
Color perception at 1150 λ — Orange01
Color perception at 1150 λ — Yellow00
Color perception at 1150 λ — Light brown10
Color perception at 1150 λ — Light blue10
Color perception at 1150 λ — Blue10
Color perception at 1150 λ — Light Purple01
Color perception at 1150 λ — White62
Color perception at 1150 λ — Grey21
Color perception at 1150 λ — Teal Green10
Color perception at 1150 λ — Green00
Color perception at 1150 λ — Light Green01
Color perception at 1150 λ — Black (no color)20
Color perception at 1150 λ — Pink00
Color perception at 1200 λ — Red11
Color perception at 1200 λ — Dark Red40
Color perception at 1200 λ — Orange51
Color perception at 1200 λ — Yellow11
Color perception at 1200 λ — Light brown10
Color perception at 1200 λ — Light blue00
Color perception at 1200 λ — Blue10
Color perception at 1200 λ — Light Purple00
Color perception at 1200 λ — White10
Color perception at 1200 λ — Grey01
Color perception at 1200 λ — Teal Green01
Color perception at 1200 λ — Green00
Color perception at 1200 λ — Light Green01
Color perception at 1200 λ — Black (no color)10
Color perception at 1200 λ — Pink00
Color perception at 1250 λ — Red10
Color perception at 1250 λ — Dark Red40
Color perception at 1250 λ — Orange61
Color perception at 1250 λ — Yellow11
Color perception at 1250 λ — Light brown10
Color perception at 1250 λ — Light blue00
Color perception at 1250 λ — Blue01
Color perception at 1250 λ — Light Purple10
Color perception at 1250 λ — White00
Color perception at 1250 λ — Grey01
Color perception at 1250 λ — Teal Green00
Color perception at 1250 λ — Green01
Color perception at 1250 λ — Light Green01
Color perception at 1250 λ — Black (no color)10
Color perception at 1250 λ — Pink00
Color perception at 1300 λ — Red111
Color perception at 1300 λ — Dark Red10
Color perception at 1300 λ — Orange12
Color perception at 1300 λ — Yellow02
Color perception at 1300 λ — Light brown00
Color perception at 1300 λ — Light blue00
Color perception at 1300 λ — Blue00
Color perception at 1300 λ — Light Purple00
Color perception at 1300 λ — White00
Color perception at 1300 λ — Grey00
Color perception at 1300 λ — Teal Green00
Color perception at 1300 λ — Green01
Color perception at 1300 λ — Light Green00
Color perception at 1300 λ — Black (no color)10
Color perception at 1300 λ — Pink10
Color perception at 1350 λ — Red102
Color perception at 1350 λ — Dark Red30
Color perception at 1350 λ — Orange01
Color perception at 1350 λ — Yellow01
Color perception at 1350 λ — Light brown00
Color perception at 1350 λ — Light blue00
Color perception at 1350 λ — Blue00
Color perception at 1350 λ — Light Purple00
Color perception at 1350 λ — White00
Color perception at 1350 λ — Grey00
Color perception at 1350 λ — Teal Green00
Color perception at 1350 λ — Green02
Color perception at 1350 λ — Light Green00
Color perception at 1350 λ — Black (no color)10
Color perception at 1350 λ — Pink10
Color perception at 1400 λ — Red61
Color perception at 1400 λ — Dark Red01
Color perception at 1400 λ — Orange61
Color perception at 1400 λ — Yellow10
Color perception at 1400 λ — Light brown00
Color perception at 1400 λ — Light blue00
Color perception at 1400 λ — Blue00
Color perception at 1400 λ — Light Purple00
Color perception at 1400 λ — White00
Color perception at 1400 λ — Grey01
Color perception at 1400 λ — Teal Green00
Color perception at 1400 λ — Green02
Color perception at 1400 λ — Light Green00
Color perception at 1400 λ — Black (no color)10
Color perception at 1400 λ — Pink10

Adverse events

Collected over The study started on 9/2015 and was completed on 8/2016, during which time the adverse event data was monitored. Each participant was assessed during their participation in the study for up to two hours.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Visual Response to IR0/21 (0%)0/21 (0%)0/21 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Visual Response to IR in Colorvision EyesVisual Response to IR in Colorblind EyesTotal
<=18 years000
Between 18 and 65 years15520
>=65 years011
Age, Continuous
Age, Continuous(years)Visual Response to IR in Colorvision EyesVisual Response to IR in Colorblind EyesTotal
Mean37.6 (22 to 58)45.7 (27 to 71)40 (22 to 71)
Sex: Female, Male
Sex: Female, Male(Participants)Visual Response to IR in Colorvision EyesVisual Response to IR in Colorblind EyesTotal
Female606
Male9615
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Visual Response to IR in Colorvision EyesVisual Response to IR in Colorblind EyesTotal
Hispanic or Latino314
Not Hispanic or Latino12517
Unknown or Not Reported000
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Visual Response to IR in Colorvision EyesVisual Response to IR in Colorblind EyesTotal
American Indian or Alaska Native202
Asian000
Native Hawaiian or Other Pacific Islander011
Black or African American000
White13518
More than one race000
Unknown or Not Reported000
Region of Enrollment
Region of Enrollment(participants)Visual Response to IR in Colorvision EyesVisual Response to IR in Colorblind EyesTotal
United States15621
08

Study locations

1 site
  • University of New Mexico
    Albuquerque, New Mexico 87131-0001, United States
09

References and documents

Publications

  • Wittenborn JS, Zhang X, Feagan CW, Crouse WL, Shrestha S, Kemper AR, Hoerger TJ, Saaddine JB; Vision Cost-Effectiveness Study Group. The economic burden of vision loss and eye disorders among the United States population younger than 40 years. Ophthalmology. 2013 Sep;120(9):1728-35. doi: 10.1016/j.ophtha.2013.01.068. Epub 2013 Apr 28. PubMed 23631946 ↗
  • Pascolini D, Mariotti SP. Global estimates of visual impairment: 2010. Br J Ophthalmol. 2012 May;96(5):614-8. doi: 10.1136/bjophthalmol-2011-300539. Epub 2011 Dec 1. PubMed 22133988 ↗
  • Stockman A, Sharpe LT, Fach C. The spectral sensitivity of the human short-wavelength sensitive cones derived from thresholds and color matches. Vision Res. 1999 Aug;39(17):2901-27. doi: 10.1016/s0042-6989(98)00225-9. PubMed 10492818 ↗
  • Friedman DS, O'Colmain BJ, Munoz B, Tomany SC, McCarty C, de Jong PT, Nemesure B, Mitchell P, Kempen J; Eye Diseases Prevalence Research Group. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 2004 Apr;122(4):564-72. doi: 10.1001/archopht.122.4.564. PubMed 15078675 ↗
  • White JP, Urban L, Nagy I. TRPV1 function in health and disease. Curr Pharm Biotechnol. 2011 Jan 1;12(1):130-44. doi: 10.2174/138920111793937844. PubMed 20932253 ↗
  • Numazaki M, Tominaga M. Nociception and TRP Channels. Curr Drug Targets CNS Neurol Disord. 2004 Dec;3(6):479-85. doi: 10.2174/1568007043336789. PubMed 15578965 ↗
  • Gracheva EO, Ingolia NT, Kelly YM, Cordero-Morales JF, Hollopeter G, Chesler AT, Sanchez EE, Perez JC, Weissman JS, Julius D. Molecular basis of infrared detection by snakes. Nature. 2010 Apr 15;464(7291):1006-11. doi: 10.1038/nature08943. Epub 2010 Mar 14. PubMed 20228791 ↗
  • Gekeler F, Shinoda K, Blatsios G, Werner A, Zrenner E. Scotopic threshold responses to infrared irradiation in cats. Vision Res. 2006 Feb;46(3):357-64. doi: 10.1016/j.visres.2005.06.023. Epub 2005 Aug 2. PubMed 16081127 ↗
  • Pardue MT, Ball SL, Hetling JR, Chow VY, Chow AY, Peachey NS. Visual evoked potentials to infrared stimulation in normal cats and rats. Doc Ophthalmol. 2001 Sep;103(2):155-62. doi: 10.1023/a:1012202410144. PubMed 11720256 ↗
  • Chow AY, Pardue MT, Chow VY, Peyman GA, Liang C, Perlman JI, Peachey NS. Implantation of silicon chip microphotodiode arrays into the cat subretinal space. IEEE Trans Neural Syst Rehabil Eng. 2001 Mar;9(1):86-95. doi: 10.1109/7333.918281. PubMed 11482368 ↗
  • Sieving PA, Frishman LJ, Steinberg RH. Scotopic threshold response of proximal retina in cat. J Neurophysiol. 1986 Oct;56(4):1049-61. doi: 10.1152/jn.1986.56.4.1049. PubMed 3783228 ↗
  • Wakabayashi K, Gieser J, Sieving PA. Aspartate separation of the scotopic threshold response (STR) from the photoreceptor a-wave of the cat and monkey ERG. Invest Ophthalmol Vis Sci. 1988 Nov;29(11):1615-22. PubMed 3182196 ↗
  • Kolb H. Simple Anatomy of the Retina. 2005 May 1 [updated 2012 Jan 31]. In: Kolb H, Fernandez E, Jones B, Nelson R, editors. Webvision: The Organization of the Retina and Visual System [Internet]. Salt Lake City (UT): University of Utah Health Sciences Center; 1995-. Available from http://www.ncbi.nlm.nih.gov/books/NBK11533/ PubMed 21413391 ↗
  • Palczewska G, Vinberg F, Stremplewski P, Bircher MP, Salom D, Komar K, Zhang J, Cascella M, Wojtkowski M, Kefalov VJ, Palczewski K. Human infrared vision is triggered by two-photon chromophore isomerization. Proc Natl Acad Sci U S A. 2014 Dec 16;111(50):E5445-54. doi: 10.1073/pnas.1410162111. Epub 2014 Dec 1. PubMed 25453064 ↗

Individual participant data

Plan to share: No

10

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Sep 2015, a primary completion of Aug 2016 and a completion of Aug 2016. It does not say whether these dates are actual or estimated.

Results were first posted in Dec 2024, 8 years 4 months after primary completion.

How these figures are worked out, and which studies are left out of them.

Registered
May 6, 2016
First posted
Sep 21, 2016
Start
Sep 2015
Primary completionActual
Aug 2016
CompletionActual
Aug 2016
Results first posted
Dec 13, 2024
Last update
Dec 13, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 13, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT02909985
Responsible party
Olivia Hopkins (Assistant Professor-Clinical Educator, University of New Mexico) — Principal investigator
First posted
Sep 21, 2016
Start date
Sep 2015
Primary completion
Aug 2016
Completion
Aug 2016
Results posted
Dec 13, 2024
Last update
Dec 13, 2024

Study contacts

Leslie Olivia Hopkins, MD
principal investigator · University of New Mexico

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion